Antipsychotics, High Prolactin Level & Risk of Breast Cancer

Today, we released the journal club #13 for our psychiatry education forum academy members. This journal club will compare the findings of this 2014 study published in the American Journal of Psychiatry with this recent study published in Dec 2021 at the Journal of Clinical Psychopharmacology.

HERE IS THE SUMMARY OF FINDINGS FROM 2014 STUDY:

HOW WAS 2021 STUDY DIFFERENT?

Journal Club #13:

Antipsychotics, High Prolactin Level & Risk of Breast Cancer

This journal club will be discussed in the following eight clinically relevant sections:

  1. Role of high prolactin levels with risk of breast cancer?
  2. Which antipsychotics are associated with an increased risk of breast cancer?
  3. Which antipsychotics are PREFERRED with less/no risk of breast cancer?
  4. Comparing recently published study on Dec 2021 (Journal of Clinical Psychopharmacology) with 2014 study (Am J Psychiatry).
  5. What is the normal prolactin level in males and females?
  6. When is the best time to measure prolactin level?
  7. What additional laboratory evaluation is needed with elevated prolactin levels?
  8. How to manage elevated prolactin levels with antipsychotics?

INTERESTED IN LEARNING MORE?

JOIN PSYCHIATRY EDUCATION FORUM ACADEMY MEMBERSHIP

This is a closed membership for medical professionals only.

  • 30+ Courses/Sections: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Coffee Club: contain short discussions with clinical experts in the field of psychiatry.
  • Essentials of Inpatient Psychiatry Book: All chapters from this book are included in the academy sections. 
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Conference Discounts: Academy members get discounted access at our conferences. 
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
 

SUBSCRIBE TO OUR EMAIL NEWSLETTER:

Related Articles